NO920591L - SUBSTITUTED BENZOFURANYL PIPERIDINES AS NOOTROPICUM - Google Patents
SUBSTITUTED BENZOFURANYL PIPERIDINES AS NOOTROPICUMInfo
- Publication number
- NO920591L NO920591L NO92920591A NO920591A NO920591L NO 920591 L NO920591 L NO 920591L NO 92920591 A NO92920591 A NO 92920591A NO 920591 A NO920591 A NO 920591A NO 920591 L NO920591 L NO 920591L
- Authority
- NO
- Norway
- Prior art keywords
- nootropicum
- piperidines
- substituted benzofuranyl
- treatment
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
4-(7-Bromo-5-methoxybenzofuran-2-yl)piperidine of the formula I <IMAGE> and its pharmaceutically utilisable salts can be used as pharmaceutical active ingredients for slowing down the degeneration of nerve cells associated with degenerative neurological disorders, and as nootropics for the treatment of disorders which respond to nootropic treatment.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH47091 | 1991-02-15 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO920591D0 NO920591D0 (en) | 1992-02-14 |
NO920591L true NO920591L (en) | 1992-08-17 |
NO179358B NO179358B (en) | 1996-06-17 |
NO179358C NO179358C (en) | 1996-09-25 |
Family
ID=4187740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO920591A NO179358C (en) | 1991-02-15 | 1992-02-14 | Use of substituted benzofuranyl piperidines as nootropics |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0499586B1 (en) |
JP (1) | JPH0570352A (en) |
KR (1) | KR920016098A (en) |
AT (1) | ATE138805T1 (en) |
AU (1) | AU655227B2 (en) |
CA (1) | CA2061015A1 (en) |
DE (1) | DE59206442D1 (en) |
DK (1) | DK0499586T3 (en) |
ES (1) | ES2087497T3 (en) |
GR (1) | GR3020155T3 (en) |
IE (1) | IE74906B1 (en) |
IL (1) | IL100889A (en) |
MX (1) | MX9200620A (en) |
NO (1) | NO179358C (en) |
NZ (1) | NZ241608A (en) |
ZA (1) | ZA921091B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993016696A1 (en) * | 1992-02-21 | 1993-09-02 | Ciba-Geigy Ag | Brofaromine as an agent for treating social phobia |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3856295T2 (en) * | 1987-10-22 | 1999-06-17 | Massachusetts Inst Technology | TREATMENT OF PREMIUM OR LATE LUTEAL PHASE SYNDROME |
-
1992
- 1992-02-06 IL IL100889A patent/IL100889A/en not_active IP Right Cessation
- 1992-02-06 AT AT92810085T patent/ATE138805T1/en not_active IP Right Cessation
- 1992-02-06 DK DK92810085.8T patent/DK0499586T3/en active
- 1992-02-06 EP EP92810085A patent/EP0499586B1/en not_active Expired - Lifetime
- 1992-02-06 DE DE59206442T patent/DE59206442D1/en not_active Expired - Fee Related
- 1992-02-06 ES ES92810085T patent/ES2087497T3/en not_active Expired - Lifetime
- 1992-02-10 AU AU10877/92A patent/AU655227B2/en not_active Ceased
- 1992-02-13 KR KR1019920002074A patent/KR920016098A/en active IP Right Grant
- 1992-02-13 CA CA002061015A patent/CA2061015A1/en not_active Abandoned
- 1992-02-13 NZ NZ241608A patent/NZ241608A/en unknown
- 1992-02-13 MX MX9200620A patent/MX9200620A/en not_active IP Right Cessation
- 1992-02-14 JP JP4028252A patent/JPH0570352A/en active Pending
- 1992-02-14 NO NO920591A patent/NO179358C/en unknown
- 1992-02-14 IE IE920486A patent/IE74906B1/en not_active IP Right Cessation
- 1992-02-14 ZA ZA921091A patent/ZA921091B/en unknown
-
1996
- 1996-06-06 GR GR960401246T patent/GR3020155T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE59206442D1 (en) | 1996-07-11 |
KR920016098A (en) | 1992-09-24 |
NO179358C (en) | 1996-09-25 |
ES2087497T3 (en) | 1996-07-16 |
AU1087792A (en) | 1992-08-20 |
EP0499586B1 (en) | 1996-06-05 |
IE920486A1 (en) | 1992-08-26 |
IL100889A (en) | 1997-03-18 |
CA2061015A1 (en) | 1992-08-16 |
NO179358B (en) | 1996-06-17 |
NZ241608A (en) | 1997-06-24 |
AU655227B2 (en) | 1994-12-08 |
GR3020155T3 (en) | 1996-09-30 |
ATE138805T1 (en) | 1996-06-15 |
JPH0570352A (en) | 1993-03-23 |
MX9200620A (en) | 1992-08-01 |
EP0499586A1 (en) | 1992-08-19 |
NO920591D0 (en) | 1992-02-14 |
ZA921091B (en) | 1992-09-30 |
IE74906B1 (en) | 1997-08-13 |
DK0499586T3 (en) | 1996-06-24 |
IL100889A0 (en) | 1992-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0574313T3 (en) | 1,4-disubstituted piperazines for the treatment of central nervous system and neuroendocrine disorders | |
NO931056D0 (en) | SULPHONAMIDO AND SULPHONAMIDOCARBONYL-PYRIDINE-2-CARBOXYLIC ACID AMIDES AND THEIR PYRIDINE-N-OXIDES, PROCEDURES FOR PREPARING THEREOF AND USING THE COMPOUNDS AS MEDICINES | |
NO961687D0 (en) | New (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans | |
FI962324A0 (en) | N-substituted azabicycloalkane derivatives as neuroleptic ASF | |
ES8705387A1 (en) | N-Aryl-N-(4-Piperidinyl)amides and pharmaceutical compositions and methods employing such compounds. | |
NO921609D0 (en) | SULPHONAMIDS AND THEIR MEDICAL USE | |
DE9290057U1 (en) | Substituted 3-aminoquinuclidines | |
NL300006I2 (en) | Imidazolylalkenoic acid derivatives. | |
GEP20022636B (en) | 4-[5-Methyl-3-Phenylisoxazol-4-Yl] Benzenesulfonamide, Its Crystal Structure B, Pharmaceutical Composition Containing The Same, Methods For Treatment Or Prophylaxis Of Disorders Caused By Cyclooxygen-2 | |
DE69216293D1 (en) | 1,4-disubstituted piperidine derivatives, their preparation and therapeutic use | |
NO180632C (en) | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents | |
FI962418A (en) | Cyclic amide derivatives as neurokinin A antagonists | |
HUT56077A (en) | Process for producing n-(imidazolyl-alkyl)-alanyl derivatives with substituents and pharmaceutical compositions containing them as active components | |
NO881308D0 (en) | DIHYDROPYRIDINAMIDES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICALS. | |
NO920591D0 (en) | SUBSTITUTED BENZOFURANYL PIPERIDINES AS NOOTROPICUM | |
NO307029B1 (en) | Use of 4-chloro-5 - [(4,5-dihydro-1H-imidazol-2-yl) -amino] -6-methoxy-2-methylpyrimidine in the preparation of pharmaceutical compositions for the treatment of hyperglycemia | |
NO982863L (en) | New compounds with analgesic effect | |
ATE139523T1 (en) | NEW COMPOUNDS AND THEIR MEDICAL USES | |
DK162839C (en) | N, 3-DIACYL-2-OXINDOL-1-CARBOXAMIDE COMPOUNDS AND 3-ACYL-2-OXINDOL COMPOUNDS FOR USE AS INTERMEDIATES IN THEIR PREPARATION | |
BR0016516A (en) | Replaced pyrroles | |
ZW6789A1 (en) | &-adrenergic receptor antagonists | |
SE8603517D0 (en) | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND PHARMACEUTICAL FORMULATION | |
EP0344982A3 (en) | Alpha-adrenergic receptor antagonists | |
MX9405318A (en) | PYRIMIDONES AND IMIDAZOLINONES FOR TREATMENT OF THE SHOCK. | |
DK286090D0 (en) | ALFA-ADRENERGE RECEPTOR ANTAGONISTS |